{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T15:24:46Z","timestamp":1786980286655,"version":"build-2736575974"},"reference-count":13,"publisher":"Springer Science and Business Media LLC","issue":"15-16","license":[{"start":{"date-parts":[[2015,5,19]],"date-time":"2015-05-19T00:00:00Z","timestamp":1431993600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Wien Klin Wochenschr"],"published-print":{"date-parts":[[2015,8]]},"DOI":"10.1007\/s00508-015-0789-4","type":"journal-article","created":{"date-parts":[[2015,5,18]],"date-time":"2015-05-18T09:55:57Z","timestamp":1431942957000},"page":"631-634","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Bevacizumab: an option for refractory epistaxis in hereditary haemorrhagic telangiectasia"],"prefix":"10.1007","volume":"127","author":[{"given":"Arno","family":"Amann","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Normann","family":"Steiner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eberhard","family":"Gunsilius","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2015,5,19]]},"reference":[{"key":"789_CR1","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1024\/0301-1526\/a000253","volume":"42","author":"A Chavan","year":"2013","unstructured":"Chavan A, Schumann-Binarsch S, Luthe L, Nickau B, Els\u00e4sser A, K\u00fchnel T, et al. Systemic therapy with bevacizumab in patients with hereditary hemorrhagic telangiectasia (HHT). VASA. 2013;42:106\u201310.","journal-title":"VASA"},{"key":"789_CR2","doi-asserted-by":"crossref","first-page":"1447","DOI":"10.1111\/j.1538-7836.2010.03860.x","volume":"8","author":"S Dupuis-Girod","year":"2010","unstructured":"Dupuis-Girod S, Bailly S, Plauchu H. Hereditary hemorrhagic telangiectasia: from molecular biology to patient care. J Thromb Haemost. 2010;8:1447\u201356.","journal-title":"J Thromb Haemost"},{"key":"789_CR3","first-page":"CD008017","volume":"8","author":"CC-T Hsu","year":"2012","unstructured":"Hsu CC-T, Kwan GNC, Thompson SA, Evans-Barns H, van Driel ML. Embolisation for pulmonary arteriovenous malformation. Cochrane Database Syst Rev. 2012;8:CD008017.","journal-title":"Cochrane Database Syst Rev"},{"key":"789_CR4","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.2214\/ajr.163.5.7976883","volume":"163","author":"E Buscarini","year":"1994","unstructured":"Buscarini E, Buscarini L, Civardi G, Arruzzoli S, Bossalini G, Piantanida M. Hepatic vascular malformations in hereditary hemorrhagic telangiectasia: imaging findings. AJR Am J Roentgenol. 1994;163:1105\u201310.","journal-title":"AJR Am J Roentgenol"},{"key":"789_CR5","doi-asserted-by":"crossref","first-page":"319","DOI":"10.2500\/105065899782102890","volume":"13","author":"VJ Lund","year":"1999","unstructured":"Lund VJ, Howard DJ. A treatment algorithm for the management of epistaxis in hereditary hemorrhagic telangiectasia. Am J Rhinol. 1999;13:319\u201322.","journal-title":"Am J Rhinol"},{"key":"789_CR6","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1136\/gut.34.4.470","volume":"34","author":"IR Sargeant","year":"1993","unstructured":"Sargeant IR, Loizou LA, Rampton D, Tulloch M, Bown SG. Laser ablation of upper gastrointestinal vascular ectasias: long term results. Gut. 1993;34:470\u20135.","journal-title":"Gut"},{"key":"789_CR7","doi-asserted-by":"crossref","first-page":"3278","DOI":"10.1111\/ajt.12499","volume":"13","author":"H Fukushima","year":"2013","unstructured":"Fukushima H, Mitsuhashi T, Oto T, Sano Y, Kusano KF, Goto K, et al. Successful lung transplantation in a case with diffuse pulmonary arteriovenous malformations and hereditary hemorrhagic telangiectasia. Am J Transplant. 2013;13:3278\u201381.","journal-title":"Am J Transplant"},{"key":"789_CR8","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1016\/j.arcmed.2005.03.037","volume":"36","author":"H Sadick","year":"2005","unstructured":"Sadick H, Bergler WF, Oulmi-Kagermann J, Naim R, Sadick M, H\u00f6rmann K, et al. Estriol induced squamous metaplasia on the nasal mucosa in patients with hereditary hemorrhagic telangiectasia. Arch Med Res. 2005;36:468\u201373.","journal-title":"Arch Med Res"},{"key":"789_CR9","doi-asserted-by":"crossref","first-page":"214","DOI":"10.4193\/Rhino09.201","volume":"49","author":"E Yaniv","year":"2011","unstructured":"Yaniv E, Preis M, Shevro J, Nageris B, Hadar T. Anti-estrogen therapy for hereditary hemorrhagic telangiectasia\u2014a long-term clinical trial. Rhinology. 2011;49:214\u20136.","journal-title":"Rhinology"},{"key":"789_CR10","doi-asserted-by":"crossref","first-page":"1494","DOI":"10.1111\/jth.12654","volume":"12","author":"S Gaillard","year":"2014","unstructured":"Gaillard S, Dupuis-Girod S, Boutitie F, Rivi\u00e8re S, Morini\u00e8re S, Hatron P-Y, et al. Tranexamic acid for epistaxis in hereditary hemorrhagic telangiectasia patients: a European cross-over controlled trial in a rare disease. J Thromb Haemost. 2014;12:1494\u2013502.","journal-title":"J Thromb Haemost"},{"key":"789_CR11","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1001\/jama.2012.250","volume":"307","author":"S Dupuis-Girod","year":"2012","unstructured":"Dupuis-Girod S, Ginon I, Saurin J-C, Marion D, Guillot E, Decullier E, et al. Bevacizumab in patients with hereditary hemorrhagic telangiectasia and severe hepatic vascular malformations and high cardiac output. JAMA. 2012;307:948\u201355.","journal-title":"JAMA"},{"key":"789_CR12","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1111\/ane.12167","volume":"129","author":"AD Kjeldsen","year":"2014","unstructured":"Kjeldsen AD, T\u00f8rring PM, Nissen H, Andersen PE. Cerebral abscesses among Danish patients with hereditary haemorrhagic telangiectasia. Acta Neurol Scand. 2014;129:192\u20137.","journal-title":"Acta Neurol Scand"},{"key":"789_CR13","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/j.clineuro.2011.10.036","volume":"114","author":"S Mathis","year":"2012","unstructured":"Mathis S, Dupuis-Girod S, Plauchu H, Giroud M, Barroso B, Ly KH, et al. Cerebral abscesses in hereditary haemorrhagic telangiectasia: a clinical and microbiological evaluation. Clin Neurol Neurosurg. 2012;114:235\u201340.","journal-title":"Clin Neurol Neurosurg"}],"container-title":["Wiener klinische Wochenschrift"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00508-015-0789-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00508-015-0789-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00508-015-0789-4","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,8,25]],"date-time":"2019-08-25T03:18:47Z","timestamp":1566703127000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00508-015-0789-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,5,19]]},"references-count":13,"journal-issue":{"issue":"15-16","published-print":{"date-parts":[[2015,8]]}},"alternative-id":["789"],"URL":"https:\/\/doi.org\/10.1007\/s00508-015-0789-4","relation":{},"ISSN":["0043-5325","1613-7671"],"issn-type":[{"value":"0043-5325","type":"print"},{"value":"1613-7671","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,5,19]]}}}